“COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY”, RMSR, vol. 3, no. 6, pp. 94–100, Jun. 2025, Accessed: Jun. 24, 2025. [Online]. Available: https://www.thermsr.com/index.php/Journal/article/view/1284